Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of MSH3 mRNA | decreases expression | 20106945 20064835
|
D002104 |
Cadmium |
Cadmium results in decreased activity of MSH3 protein | decreases activity | 16677676
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of MSH3 mRNA | affects expression | 17484886
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of MSH3 mRNA] | decreases expression|decreases reaction | 11007951
|
D003520 |
Cyclophosphamide |
Cyclophosphamide results in decreased expression of MSH3 mRNA | decreases expression | 11906922
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of MSH3 mRNA | decreases expression | 20106945
|
C452423 |
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine |
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine results in decreased expression of MSH3 mRNA | decreases expression | 16052530
|
D013749 |
Tetrachlorodibenzodioxin |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of MSH3 mRNA] | decreases expression|decreases reaction | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of MSH3 mRNA | decreases expression | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of MSH3 mRNA | decreases expression | 16962184
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of MSH3 mRNA | increases expression | 19465110
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.18 | 15322242 14514962 11752688 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.03 | 20464547 20127859 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.78 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.71 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.17 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.38 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
4.90 | 15014928 |
MESH:D050197 |
Atherosclerosis |
|
Cadmium |
3.77 | 15687053 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.29 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.91 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.90 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
1.90 | 12006526 11325840 15093573 18234424 17020986 17388661 18323546 15136595 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.90 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
4.08 | 16192424 15721981 3786805 15700767 16227642 16097048 16050911 18705752 10355542 16124888 16011737 15673190 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
3.39 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
3.39 | 19701751 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
5.23 | 16152834 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
3.63 | 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.10 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 18850075 16120746 18670907 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cadmium |
7.45 | 17332340 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.45 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.38 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.09 | 19486331 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.19 | 8697196 15668235 15340226 16354765 12621046 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
5.36 | 15276878 10700343 18093676 16614059 15643279 16651033 12388444 18710439 18295254 17010015 12913760 10498854 18433785 16989017 16413132 11948286 18483878 17979934 12161096 18372110 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
4.27 | 15331540 11751995 10990075 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.28 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
3.92 | 7440962 3732212 2869522 15998439 15968718 19336974 19085960 17522070 21278145 11566570 4309450 3786805 16177239 6623471 9327722 7179309 16227642 15027814 10915739 7120509 6884620 10092053 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.92 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.93 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.61 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.28 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.25 | 9294722 10568697 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
4.52 | 11006010 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.06 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.19 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
8.53 | 12631006 17595544 12795759 61145 16045604 19224547 15959796 16239168 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.53 | 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
16.58 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
16.58 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
16.58 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.56 | 8708960 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.85 | 11389073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
5.34 | 16376943 15172196 11014644 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.82 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.82 | 10048152 11294989 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.76 | 15720958 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
5.60 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.91 | 14986274 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.88 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.20 | 16120746 15340226 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
4.00 | 17606976 16135485 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 16959395 16354765 8697196 18606429 15340226 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.87 | 16899240 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.21 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.21 | 18670907 18850075 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.39 | 15338365 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
5.71 | 16076520 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
3.77 | 7193160 16517039 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.96 | 12200463 12878042 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.58 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.82 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium |
6.70 | 16322080 16226777 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.70 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.93 | 12371664 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
3.59 | 10602166 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.58 | 17008537 17296974 17658394 18587576 18172266 17802794 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
4.26 | 10373061 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
5.30 | 10052129 11830472 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.92 | 21278145 16943688 16239168 11408273 17157831 16221502 17174718 17334410 11903743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
2.34 | 12609069 12741479 18339082 14748882 16033810 17805973 15650968 18054572 10355542 12898905 15876570 12632514 17631135 17714472 15893842 17481882 18263696 17708605 15362042 17698563 12632512 17557913 16097048 17869086 17823541 18472332 14716496 14620537 18705752 15996030 14716833 18376398 12445421 15931870 15057751 12546737 15959796 18251166 18481824 18472094 16192424 18277467 17976157 18395914 16015684 16638106 13678700 17761835 18156304 18006644 16011737 15818738 18279442 17922224 17640975 18210741 18420326 15730626 17565644 12649538 18395095 12958196 18187930 16248980 14724832 12389079 17900296 15925388 16027843 12445418 20821823 16136751 17525996 12586293 17944888 14512876 11481614 15673190 15123356 15338365 18166357 15370692 12666154 18412020 18205269 18317297 12667390 17721639 18429990 16116963 18418968 17766677 15052691 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.34 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.13 | 15720792 16246199 15830285 16964402 17285989 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.47 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.92 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
7.82 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
7.82 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.82 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
6.23 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.23 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.24 | 18520028 20464547 20135361 17053015 6695378 18816296 20869020 18569708 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.24 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
4.00 | 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
4.86 | 16675587 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
4.37 | 11911406 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
5.11 | 16388313 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.16 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.37 | 16381670 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.21 | 12213967 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.61 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
5.61 | 18854779 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.82 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.50 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.49 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.75 | 8761367 15176712 16115947 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
5.23 | 8761367 12837982 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
4.58 | 8291058 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
5.05 | 16517039 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
3.82 | 18093676 12161096 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
3.25 | 11332152 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Cadmium |
5.72 | 15687053 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.44 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
3.92 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.53 | 11222880 11896295 11399792 11118676 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 18355840 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.69 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cadmium |
2.69 | 17075824 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.69 | 17136230 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.30 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
3.36 | 16636934 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
5.08 | 16636934 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.80 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.80 | 16192470 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.85 | 16517039 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20155912 2093021 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
5.39 | 12837982 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.28 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
N-(4-bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine |
5.03 | 16940797 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.55 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
5.55 | 14692829 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.36 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.82 | 17120751 |